News Sentiment

TVTX sentiment intelligence

Travere Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 56.59 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.6% over one week, +8.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Dow, S&P 500, Nasdaq Futures Gain As Trump Signals Iran Talks Could Resume: Why SNDK, BMNR, ORCL, BE, TVTX Kept Traders On Edge Today

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -0.6% Price digesting
Trend fit Trend active 8.7% over four weeks
Fair value 192.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 41
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
TradingView 10
Stock Titan 9
simplywall.st 4
Simply Wall Street 3
Investing.com 3
MT Newswires 3
Stocktwits 2

Event Lens

What the news is about

Classified themes
Market update 41
Earnings 13
Analyst action 5
Regulatory and legal 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
TradingKey Direct company coverage

Travere Therapeutics Inc (TVTX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Travere Therapeutics Inc (TVTX), noting its current valuation score is 9.85, ranking 11th in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -246.62 and mentions that relevant data for P/B, P/S,

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 01:40
Source
TradingKey
TradingKey Direct company coverage

Travere Therapeutics Inc (TVTX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an in-depth look into the shareholder structure of Travere Therapeutics Inc (TVTX), detailing its major shareholders and institutional holdings. It lists key investment firms and their respective proportions, along with a historical overview of institutional

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 09:10
Source
TradingKey